Original Research
Published on 12 Sep 2023
Genomic profiling and sites of metastasis in non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1212788
- 2,462 views
- 6 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,703 articles
Original Research
Published on 11 Sep 2023
Risk factor analysis for major mediastinal vessel invasion in thymic epithelial tumors based on multi-slice CT Imaging
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1239419
- 1,278 views
Original Research
Published on 11 Sep 2023
Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1248690
- 1,678 views
Editorial
Published on 08 Sep 2023
Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1277542
- 1,238 views
Original Research
Published on 06 Sep 2023
Right upper lobe segmentectomy and subsegmentectomy guided by classification pattern of peripheral segmental veins
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1179570
- 1,574 views
- 1 citation
Mini Review
Published on 06 Sep 2023
Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1211815
- 6,199 views
- 7 citations
Clinical Trial
Published on 05 Sep 2023
Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1200625
- 2,021 views
- 6 citations
Systematic Review
Published on 04 Sep 2023
Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1247879
- 6,670 views
- 8 citations
Clinical Trial
Published on 30 Aug 2023
Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1204726
- 2,482 views
- 2 citations
Case Report
Published on 29 Aug 2023
Novel PPFIA1-ALK, ALK-C2orf91(intergenic) double-fusion responded well to alectinib in an advanced lung adenocarcinoma patient: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1264820
- 1,823 views
- 3 citations
Original Research
Published on 28 Aug 2023
Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1215524
- 6,351 views
- 1 citation
Review
Published on 28 Aug 2023
Potential targets of natural medicines: preventing lung cancer pre-metastatic niche formation by regulating exosomes
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1137007
- 2,286 views
- 1 citation
Original Research
Published on 28 Aug 2023
Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1253414
- 3,192 views
- 2 citations
Original Research
Published on 25 Aug 2023
Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy: the Lung PLUS study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1220248
- 1,858 views
Systematic Review
Published on 24 Aug 2023
Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1198768
- 2,639 views
- 3 citations
Original Research
Published on 23 Aug 2023
The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1210945
- 1,539 views